MECHANISM OF MULTIHORMONAL REGULATION OF RAT GENE 33
大鼠基因33的多激素调节机制
基本信息
- 批准号:6107345
- 负责人:
- 金额:$ 12.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-08-01 至 1999-07-31
- 项目状态:已结题
- 来源:
- 关键词:SDS polyacrylamide gel electrophoresis affinity chromatography biological signal transduction cell growth regulation chimeric proteins clone cells cyclic AMP gene expression growth factor hormone regulation /control mechanism immunofluorescence technique laboratory rabbit nucleic acid sequence polymerase chain reaction protein structure function protein tyrosine kinase regulatory gene transfection western blottings
项目摘要
The long term objective of this research project is to contribute to a
better understanding of the mechanisms by which growth factor act to
control growth in mammalian cells. The specific gene to be studied, g33,
has been cloned and characterized at the sequence level. This gene has
many interesting properties, including widespread tissue distribution (6,
and L.A. Balogh, K._L. Lee, and F.T. Kenney, unpublished observations) and
inducibility, and the potential for producing two discrete protein
products. The function of the g33 proteins has remained elusive. Sequence
analysis of the predicted protein sequence revealed that g33 protein
contains several regions that are similar to functional or regulatory
domains of other known proteins. Using amino acid sequence derived from
the PROSITE database we compared g33 protein (PIR entry number S03116) to
numerous entries in PROSITE using the PROSIS protein analysis software. We
found several potential PKC phosphorylation sites, casein kinase II
phosphorylation sites. cAMP/cGMP dependent kinase phosphorylation site, N-
myristolation site, tyrosine sulfatation site, a region similar to a DEAD
box, and a Class I SH3 domain- binding site. No SH3 or SH2 domains or SH2
domain binding sites we found. The strongest homology to protein sequences
in the NCB1 database found using the BLAST algorithm is tot he human non-
receptor tyrosine kinase called ACK that inhibits the GTPase activity of
p21 cdc42 (23), and the homology is restricted to portions of the C-
terminal half of the protein including a Class I SH3 domain binding site,
and do not include the kinase catalytic domain, the SH3 domain or the
Cdc42Hs binding site. The region in g33 protein where the Class I SH3-
domain binding site is located has some homology to the ACK protein
sequence, which also possesses a Class I SH3 domain binding site.
Other homologies that come out in the protein sequence analysis are to
proline-rich protein, but the alignments are poor and scattered and
restricted mainly to the proline rich regions. The biological function of
the gene 33 protein products cannot be inferred from the amino acid
sequence and needs to be elucidated experimentally. G33 cDNAs were re-
isolated by two different research groups that study genes whose expression
increases independent of de novo protein synthesis during the transition
from quiescence to proliferation. Such genes, known as immediate-early
genes, are postulated to play regulatory roles in the growth response. G33
sequences were cloned from regenerating rat liver cDNA library and from
serum-stimulated NIH 3T3 cells, and was shown to function as an immediate
early gene in regenerating liver and in mitogen treated H-35 and Balb/C 3T3
cells. These results suggest that g33 participates in the transition from
quiescence to proliferation in many mitogen-treated cells in addition to
its previously reported involvement in hormone responses. The widespread
and perhaps ubiquitous tissue distribution of g33 suggests that this gene
may participate in a number of different responses perhaps as a member of
a common signal transduction pathway. The presence of possible post-
transcriptional modification sites (such as PKC and cAMP dependent protein
kinase sites) and protein-protein interaction domains such as the SH3
domain binding site give strength to these hypotheses and suggest
experimental targets for future studies on g33 function. In order to
analyze in depth the function and expression of this multihormonally-
regulated gene, we will express g33 protein in three different expression
vectors in order to prepare polyclonal antibodies for analysis of g33
expression at the protein level; express g33 protein as a green fluorescent
protein fusion protein to study the localization of g33 protein within the
cell in vivo and if it varies in response to known mRNAg33 regulators; and
to determine whether g33 protein interacts with other cellular proteins
through its SH3 domain binding site or other regions, and whether protein
phosphorylation plays a role in those interactions.
The proposed project will enable students to be trained in basic research
techniques and to give them an experience in studying the effects of
structure on function, which will serve as a catalyst for a future research
career in biomedical sciences. The students will involve themselves in all
aspects of scientific research.
该研究项目的长期目标是为
更好地了解生长因子的作用机制
控制哺乳动物细胞的生长。 要研究的具体基因,g33,
已在序列水平上进行克隆和表征。 这个基因有
许多有趣的特性,包括广泛的组织分布(6,
和 L.A. Balogh,K._L。李和 F.T.肯尼,未发表的观察)和
诱导性,以及产生两种离散蛋白质的潜力
产品。 g33 蛋白的功能仍然难以捉摸。 顺序
对预测的蛋白质序列的分析表明,g33 蛋白质
包含几个与功能或监管相似的区域
其他已知蛋白质的结构域。 使用衍生自的氨基酸序列
我们将 PROSITE 数据库中的 g33 蛋白(PIR 条目号 S03116)与
PROSITE 中使用 PROSIS 蛋白质分析软件的大量条目。 我们
发现了几个潜在的 PKC 磷酸化位点,酪蛋白激酶 II
磷酸化位点。 cAMP/cGMP 依赖性激酶磷酸化位点,N-
肉豆蔻酰化位点,酪氨酸硫酸化位点,类似于DEAD的区域
框和 I 类 SH3 域结合位点。 无 SH3 或 SH2 域或 SH2
我们发现的域结合位点。 与蛋白质序列最强的同源性
在NCB1数据库中发现使用BLAST算法是人类非
受体酪氨酸激酶称为 ACK,可抑制 GTP 酶活性
p21 cdc42 (23),同源性仅限于 C- 的部分
蛋白质的末端一半包括 I 类 SH3 结构域结合位点,
并且不包括激酶催化结构域、SH3 结构域或
Cdc42Hs 结合位点。 g33 蛋白中 I 类 SH3- 所在的区域
结构域结合位点所在位置与 ACK 蛋白有一定的同源性
序列,还具有 I 类 SH3 结构域结合位点。
蛋白质序列分析中出现的其他同源性是
富含脯氨酸的蛋白质,但排列较差且分散,
主要限于脯氨酸丰富的区域。 的生物学功能
基因33的蛋白质产物不能从氨基酸推断出来
的顺序,需要通过实验来阐明。 G33 cDNA 被重新
由两个不同的研究小组分离出来,研究其表达的基因
在转变过程中增加独立于从头蛋白质合成
从静止到增殖。 这种基因被称为即早基因
基因被认为在生长反应中发挥调节作用。 G33
从再生大鼠肝脏 cDNA 文库中克隆序列
血清刺激的 NIH 3T3 细胞,并被证明可以作为立即
再生肝脏和经丝裂原处理的 H-35 和 Balb/C 3T3 中的早期基因
细胞。 这些结果表明 g33 参与了从
除了许多经有丝分裂原处理的细胞中的增殖静止
先前报道其参与激素反应。 广泛流传的
也许 g33 无处不在的组织分布表明该基因
可能作为成员参与许多不同的反应
共同的信号转导途径。 可能存在的后
转录修饰位点(例如 PKC 和 cAMP 依赖性蛋白
激酶位点)和蛋白质-蛋白质相互作用结构域,例如 SH3
域结合位点增强了这些假设并表明
g33功能未来研究的实验目标。 为了
深入分析这种多激素的功能和表达
调控基因,我们将以三种不同的表达方式表达g33蛋白
载体以制备用于 g33 分析的多克隆抗体
蛋白质水平的表达;将 g33 蛋白表达为绿色荧光
蛋白质融合蛋白,用于研究 g33 蛋白在
体内细胞以及它是否响应已知的 mRNAg33 调节剂而变化;和
确定 g33 蛋白是否与其他细胞蛋白相互作用
通过其 SH3 结构域结合位点或其他区域,以及蛋白质是否
磷酸化在这些相互作用中发挥作用。
拟议的项目将使学生能够接受基础研究方面的培训
技术并给予他们研究影响的经验
功能结构,这将成为未来研究的催化剂
生物医学科学的职业生涯。 学生将全身心投入
科学研究的各个方面。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CARMEN LYDIA CADILLA其他文献
CARMEN LYDIA CADILLA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CARMEN LYDIA CADILLA', 18)}}的其他基金
Mechanisms of TWIST bHLH Transcription Factors Binding to Functional Target Regions
TWIST bHLH 转录因子与功能靶区结合的机制
- 批准号:
10401753 - 财政年份:2021
- 资助金额:
$ 12.07万 - 项目类别:
Mechanisms of TWIST bHLH Transcription Factors Binding to Functional Target Regions
TWIST bHLH 转录因子与功能靶区结合的机制
- 批准号:
10643822 - 财政年份:2021
- 资助金额:
$ 12.07万 - 项目类别:
Mechanisms of TWIST bHLH Transcription Factors Binding to Functional Target Regions
TWIST bHLH 转录因子与功能靶区结合的机制
- 批准号:
10089973 - 财政年份:2021
- 资助金额:
$ 12.07万 - 项目类别:
MBRS RISE at the UPR Medical Sciences Campus
UPR 医学科学校区的 MBRS RISE
- 批准号:
7903815 - 财政年份:2009
- 资助金额:
$ 12.07万 - 项目类别:
IDENTIFICATION OF THE GENE(S) INVOLVED IN TYPE III FOCAL FACIAL DERMAL DYSPLASIA
III 型局灶性面部皮肤发育不良涉及的基因的鉴定
- 批准号:
7609650 - 财政年份:2007
- 资助金额:
$ 12.07万 - 项目类别:
A3: HUMAN MOLECULAR GENETICS: SICKLE CELL, THALASSEMIA, HEMOPHILIA
A3:人类分子遗传学:镰状细胞、地中海贫血、血友病
- 批准号:
6646692 - 财政年份:2002
- 资助金额:
$ 12.07万 - 项目类别:
A3: HUMAN MOLECULAR GENETICS: SICKLE CELL, THALASSEMIA, HEMOPHILIA
A3:人类分子遗传学:镰状细胞、地中海贫血、血友病
- 批准号:
6657690 - 财政年份:2002
- 资助金额:
$ 12.07万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 12.07万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 12.07万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 12.07万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 12.07万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 12.07万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 12.07万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 12.07万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 12.07万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 12.07万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 12.07万 - 项目类别:
Collaborative Research and Development Grants














{{item.name}}会员




